Muriuki J, Mentzer A, Band G, Gilchrist J, Carstensen T, Lule S
Sci Adv. 2019; 5(9):eaaw0109.
PMID: 31517041
PMC: 6726445.
DOI: 10.1126/sciadv.aaw0109.
Vlasveld L, Janssen R, Bardou-Jacquet E, Venselaar H, Hamdi-Roze H, Drakesmith H
Pharmaceuticals (Basel). 2019; 12(3).
PMID: 31505869
PMC: 6789780.
DOI: 10.3390/ph12030132.
Pietrangelo A
Haematologica. 2017; 102(12):1972-1984.
PMID: 29101207
PMC: 5709096.
DOI: 10.3324/haematol.2017.170720.
Neves J, Ramos M, Moreira A, Silva T, Gomes M, Rodrigues P
Sci Rep. 2017; 7(1):14793.
PMID: 29093559
PMC: 5665920.
DOI: 10.1038/s41598-017-14933-5.
Sabelli M, Montosi G, Garuti C, Caleffi A, Oliveto S, Biffo S
Hepatology. 2016; 65(5):1512-1525.
PMID: 28027576
PMC: 5413859.
DOI: 10.1002/hep.29007.
Ironing out Ferroportin.
Drakesmith H, Nemeth E, Ganz T
Cell Metab. 2015; 22(5):777-87.
PMID: 26437604
PMC: 4635047.
DOI: 10.1016/j.cmet.2015.09.006.
Cardiac ferroportin regulates cellular iron homeostasis and is important for cardiac function.
Lakhal-Littleton S, Wolna M, Carr C, Miller J, Christian H, Ball V
Proc Natl Acad Sci U S A. 2015; 112(10):3164-9.
PMID: 25713362
PMC: 4364209.
DOI: 10.1073/pnas.1422373112.
Iron, inflammation, and early death in adults with sickle cell disease.
van Beers E, Yang Y, Raghavachari N, Tian X, Allen D, Nichols J
Circ Res. 2014; 116(2):298-306.
PMID: 25378535
PMC: 4297524.
DOI: 10.1161/CIRCRESAHA.116.304577.
Ceruloplasmin-ferroportin system of iron traffic in vertebrates.
Musci G, Polticelli F, Bonaccorsi di Patti M
World J Biol Chem. 2014; 5(2):204-15.
PMID: 24921009
PMC: 4050113.
DOI: 10.4331/wjbc.v5.i2.204.
Out of balance--systemic iron homeostasis in iron-related disorders.
Steinbicker A, Muckenthaler M
Nutrients. 2013; 5(8):3034-61.
PMID: 23917168
PMC: 3775241.
DOI: 10.3390/nu5083034.
Reduced sensitivity of the ferroportin Q248H mutant to physiological concentrations of hepcidin.
Nekhai S, Xu M, Foster A, Kasvosve I, Diaz S, Machado R
Haematologica. 2012; 98(3):455-63.
PMID: 23065513
PMC: 3659936.
DOI: 10.3324/haematol.2012.066530.
Ferroportin-mediated iron transport: expression and regulation.
Ward D, Kaplan J
Biochim Biophys Acta. 2012; 1823(9):1426-33.
PMID: 22440327
PMC: 3718258.
DOI: 10.1016/j.bbamcr.2012.03.004.
Hepcidin and ferroportin: the new players in iron metabolism.
De Domenico I, Ward D, Kaplan J
Semin Liver Dis. 2011; 31(3):272-9.
PMID: 21901657
PMC: 3706197.
DOI: 10.1055/s-0031-1286058.
The molecular basis of iron overload disorders and iron-linked anemias.
Kaplan J, Ward D, De Domenico I
Int J Hematol. 2011; 93(1):14-20.
PMID: 21210258
DOI: 10.1007/s12185-010-0760-0.
Ferroportin (SLC40A1) Q248H mutation is associated with lower circulating plasma tumor necrosis factor-alpha and macrophage migration inhibitory factor concentrations in African children.
Kasvosve I, Debebe Z, Nekhai S, Gordeuk V
Clin Chim Acta. 2010; 411(17-18):1248-52.
PMID: 20460119
PMC: 2921676.
DOI: 10.1016/j.cca.2010.04.031.
Ferroportin Q248h, dietary iron, and serum ferritin in community African-Americans with low to high alcohol consumption.
Gordeuk V, Diaz S, Onojobi G, Kasvosve I, Debebe Z, Edossa A
Alcohol Clin Exp Res. 2008; 32(11):1947-53.
PMID: 18782341
PMC: 3369540.
DOI: 10.1111/j.1530-0277.2008.00782.x.
Liver iron transport.
Graham R, Chua A, Herbison C, Olynyk J, Trinder D
World J Gastroenterol. 2007; 13(35):4725-36.
PMID: 17729394
PMC: 4611194.
DOI: 10.3748/wjg.v13.i35.4725.
SLC40A1 Q248H allele frequencies and Q248H-associated risk of non-HFE iron overload in persons of sub-Saharan African descent.
Barton J, Acton R, Lee P, West C
Blood Cells Mol Dis. 2007; 39(2):206-11.
PMID: 17490902
PMC: 1986732.
DOI: 10.1016/j.bcmd.2007.03.008.
The flatiron mutation in mouse ferroportin acts as a dominant negative to cause ferroportin disease.
Zohn I, De Domenico I, Pollock A, Ward D, Goodman J, Liang X
Blood. 2007; 109(10):4174-80.
PMID: 17289807
PMC: 1885502.
DOI: 10.1182/blood-2007-01-066068.
Association of ferroportin Q248H polymorphism with elevated levels of serum ferritin in African Americans in the Hemochromatosis and Iron Overload Screening (HEIRS) Study.
Rivers C, Barton J, Gordeuk V, Acton R, Speechley M, Snively B
Blood Cells Mol Dis. 2007; 38(3):247-52.
PMID: 17276706
PMC: 3727273.
DOI: 10.1016/j.bcmd.2006.12.002.